Although our study found that CRYAB and p53 are positively correlated in ovarian cancer, whether CRYAB selectively acts on the TP53 gene in ovarian cancer, promotes p53 overexpression, and thus promotes ovarian cancer invasion and metastasis requires further study. The gene discussed is TP53; the disease is ovarian carcinoma.